The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of nutritional status on recurrence-free survival (RFS) in patients with locally advanced oesophagogastric adenocarcinoma (LA-OGA) treated with FLOT therapy.
 
Keiji Sugiyama
Honoraria - Daiichi Sankyo; Eisai; MSD; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
 
Sacheen Kumar
No Relationships to Disclose
 
M. Asif Chaudry
No Relationships to Disclose
 
Nikhil Patel
No Relationships to Disclose
 
Pranav Patel
No Relationships to Disclose
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); Bayer (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); Roche (Inst)
 
Naureen Starling
Honoraria - Astellas Pharma; AstraZeneca; BMS; BMS; Daiichi Sankyo; GlaxoSmithKline; Merck; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Natera; Pierre Fabre; Pierre Fabre; Pierre Fabre; Seagen; SERVIER; SERVIER; SERVIER; Tempus
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen; Moderna Therapeutics; MSD Oncology; Seagen; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb; GlaxoSmithKline; Guardant Health; MSD Oncology; SERVIER; Takeda
(OPTIONAL) Uncompensated Relationships - Guardant Health
 
Sheela Rao
Honoraria - Bayer; Boehringer Ingelheim; Incyte; Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Hookipa Pharma; Merck; Seagen
Travel, Accommodations, Expenses - SERVIER
 
Charlotte Fribbens
No Relationships to Disclose
 
Ian Chau
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; BioNTech SE; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Elevation Oncology; GlaxoSmithKline; Jazz Pharmaceuticals; Novartis; OncXerna Therapeutics; Seagen; SERVIER; Taiho Oncology; Takeda
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - BMS; Jazz Pharmaceuticals; SERVIER; Takeda